U.S. Department of Health and Human Services
Sheila Kumar
 

 Contact Info

 
Tel: 301-496-9730
Email: sheila.kumar@nih.gov
 

 Select Experience

 
  • Fellow, Gastroenterology and HepatologyDivision of Gastroenterology, Department of Medicine, Stanford University School of Medicine2011-2014
  • Research Fellow (Pancreas)Pancreas Cancer Genetics and Prevention Program, Division of Digestive and Liver Diseases, Department of Medicine, New York-Presbyterian/Columbia University Medical Center2010-2011
  • Intern and ResidentDepartment of Medicine, New York-Presbyterian/Columbia University Medical Center2007-2010
  • M.S. in Epidemiology and Clinical ResearchDepartment of  Health Research and Policy, Stanford University School of Medicine2013-2014
  • M.D.Yale University School of Medicine2003-2007
  • B.A. with HonorsJohns Hopkins University1999-2003
 

 Related Links

 

Sheila Kumar, M.D., M.S.

Staff Clinician, Gastroenterology SectionDigestive Disease Branch
Specialties
  • Cancer Biology
  • Clinical Research
  • Epidemiology/Population Sciences

​Publications

A selection of recent and significant publications can be viewed below.

Publications
Hassid BG, Lucas AL, Salomao M, Weng C, Liu F, Khanna LG, Kumar S, Hwang C, Chabot JA, Frucht H. Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer. Pancreas. 2014 Oct; 43 (43; 7; 2014 Oct):1073-7. [Full Text/Abstract]
Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, Chabot JA, Chung WK, Frucht H. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts. Cancer. 2014 Jul 1; 120 (2014 Jul 1; 120; 13):1960-7. [Full Text/Abstract]
Kumar S, Gunaratnam N, Ladabaum U. Response:. Gastrointest Endosc. 2014 Jun; 79 (6; 79; 2014 Jun):1031-2. [Full Text/Abstract]
Kumar S, Fioritto A, Mitani A, Desai M, Gunaratnam N, Ladabaum U. Optical biopsy of sessile serrated adenomas: do these lesions resemble hyperplastic polyps under narrow-band imaging?. Gastrointest Endosc. 2013 Dec; 78 (6; 2013 Dec; 78):902-9. [Full Text/Abstract]
Lucas AL, Shakya R, Lipsyc MD, Mitchel EB, Kumar S, Hwang C, Deng L, Devoe C, Chabot JA, Szabolcs M, Ludwig T, Chung WK, Frucht H. High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions. Clin Cancer Res. 2013 Jul 1; 19 (19; 13; 2013 Jul 1):3396-403. [Full Text/Abstract]
Scherl EJ, Kumar S, Warren RU. Review of the safety and efficacy of ustekinumab. Therap Adv Gastroenterol. 2010 Sep; 3 (2010 Sep; 3; 5):321-8. [Full Text/Abstract]